Catalyst Wire Dossier Catalyst Wire Dossier

Selatinib Ditosilate Tablets

selatinib ditosilate · Qilu Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Selatinib Ditosilate Tablets, covering 2013-08-30 to 2013-08-30. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ib Study of Selatinib Ditosilate Tablets in Patients With Advanced Breast Cancer [Phase 1]

See pricing